Friday, September 25, 2020 12:37:28 PM
If you are naive to investing and NWBO is your chance to change your life, then read this:
I’m going to assume perhaps 1/2 the trades this week were short sales, which is usually the case with surges in a stock, especially easily controlled OTC stocks. Price per share is driven down. Once the shorts cover, the price will stabilize and rise a bit. Upon any positive news, the price rises again and we rinse and repeat. Shorts come in and walk it down to a lower price, the price stabilizes and increase a to a higher level. Then rinse and repeat. This is the OTC market place. This has been the case with NWBO the entire year, nothing new here. After the shorting, NWBO will end up at a price per share higher than before the surge. This is why this board is being filled with potential for bad news to raise investor anxiety and create doubt.
The difference:
If TLD is released today, it most likely going to put the stock through the roof and the shorts get a margin call and get hurt very bad. It’s important to remember NWBO is a minute fraction of a Market Makers portfolio, so all the gains they have made in past are worth it. The majority of shorting is done by computer algorithms. The algorithm follows the stock until the short strategy doesn’t work anymore and then moves on. However, they will be back as soon as the opportunity presents itself.
What is happening right now is the trap. The shorts are in a very bad place and desperately trying to get out of it. The TLD is coming by the 30th. NWBO is not obligated to telegraph anything and don’t want to, their inactions are trapping the shorts by default. With no news algorithms can’t react. The longer the shorting goes on the worse it will be.
Lastly, if anyone doubts what is clinically already known, please review Hspooner’s post #310332 quoted below. It’s tells you everything you clinically need to know:
“ The Science!
1. DCVax-Direct DCs produce very large quantities of cytokines, such as TNF-a and interleukin 12
2. These cytokines have 2 key functions:
- direct biological effects
- indicators of potential effectiveness of DCs
3. There are multiple observed major biological effects:
- DCVax-Direct causes rapid influx of T-cells into tumors
- DCVax-Direct causes massive necrosis in injected tumors
- DCVax-Direct mobilizes systemic anti-tumor T-cell responses
4. The quantity of cytokines correlates with survival
5. The effects are produced without significant toxicity such as cytokine storms
4. 5.
The Results!
DCVax-Direct Phase I Trial: Actual vs. Predicted Survival
Using the MDACC Score, predicted survival was determined for all DCVax- Direct Phase I patients and compared to actual survival (the MDACC Score was calculated from patients treated with other experimental therapies)
Outcome: 76% of evaluable patients in the DCVax-Direct trial exceeded their predicted survival time, by an average
of 14.3 months”
I also recommend following Biosectinvestor, he knows what he is talking about and has great credibility.
I’m going to assume perhaps 1/2 the trades this week were short sales, which is usually the case with surges in a stock, especially easily controlled OTC stocks. Price per share is driven down. Once the shorts cover, the price will stabilize and rise a bit. Upon any positive news, the price rises again and we rinse and repeat. Shorts come in and walk it down to a lower price, the price stabilizes and increase a to a higher level. Then rinse and repeat. This is the OTC market place. This has been the case with NWBO the entire year, nothing new here. After the shorting, NWBO will end up at a price per share higher than before the surge. This is why this board is being filled with potential for bad news to raise investor anxiety and create doubt.
The difference:
If TLD is released today, it most likely going to put the stock through the roof and the shorts get a margin call and get hurt very bad. It’s important to remember NWBO is a minute fraction of a Market Makers portfolio, so all the gains they have made in past are worth it. The majority of shorting is done by computer algorithms. The algorithm follows the stock until the short strategy doesn’t work anymore and then moves on. However, they will be back as soon as the opportunity presents itself.
What is happening right now is the trap. The shorts are in a very bad place and desperately trying to get out of it. The TLD is coming by the 30th. NWBO is not obligated to telegraph anything and don’t want to, their inactions are trapping the shorts by default. With no news algorithms can’t react. The longer the shorting goes on the worse it will be.
Lastly, if anyone doubts what is clinically already known, please review Hspooner’s post #310332 quoted below. It’s tells you everything you clinically need to know:
“ The Science!
1. DCVax-Direct DCs produce very large quantities of cytokines, such as TNF-a and interleukin 12
2. These cytokines have 2 key functions:
- direct biological effects
- indicators of potential effectiveness of DCs
3. There are multiple observed major biological effects:
- DCVax-Direct causes rapid influx of T-cells into tumors
- DCVax-Direct causes massive necrosis in injected tumors
- DCVax-Direct mobilizes systemic anti-tumor T-cell responses
4. The quantity of cytokines correlates with survival
5. The effects are produced without significant toxicity such as cytokine storms
4. 5.
The Results!
DCVax-Direct Phase I Trial: Actual vs. Predicted Survival
Using the MDACC Score, predicted survival was determined for all DCVax- Direct Phase I patients and compared to actual survival (the MDACC Score was calculated from patients treated with other experimental therapies)
Outcome: 76% of evaluable patients in the DCVax-Direct trial exceeded their predicted survival time, by an average
of 14.3 months”
I also recommend following Biosectinvestor, he knows what he is talking about and has great credibility.
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
